Covered recipient · General Payments record
SAM JIN YEE
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2018–2021
$990.97
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $196.18 | 11 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $46.71 | 3 |
| GlaxoSmithKline, LLC. | $43.66 | 2 |
| Allergan Inc. | $21.49 | 1 |
| DEXCOM, INC. | $20.64 | 1 |
| Janssen Pharmaceuticals, Inc | $17.85 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.23 | 1 |
| Alfasigma USA, Inc. | $15.66 | 1 |
| SANOFI-AVENTIS U.S. LLC | $13.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alfasigma USA, Inc. | $15.66 | 02/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 853053101 | CMS |
| Allergan, Inc. | $21.49 | 04/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 792990763 | CMS |
| DEXCOM, INC. | $20.64 | 04/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 845304627 | CMS |
| GlaxoSmithKline, LLC. | $23.59 | 01/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 802930965 | CMS |
| GlaxoSmithKline, LLC. | $20.07 | 05/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 802757165 | CMS |
| Janssen Pharmaceuticals, Inc | $17.85 | 04/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 787734769 | CMS |
| Novartis Pharmaceuticals Corporation | $16.23 | 04/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 813378247 | CMS |
| Novo Nordisk Inc | $15.26 | 03/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811241035 | CMS |
| Novo Nordisk Inc | $16.51 | 04/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811241041 | CMS |
| Novo Nordisk Inc | $14.94 | 05/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811241045 | CMS |
| SANOFI-AVENTIS U.S. LLC | $13.94 | 05/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 843475683 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.